Marker Therapeutics, Inc. , a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States.
Marker Therapeutics stock last closed at $4.34, up 0.35% from the previous day, and has increased 435.19% in one year. It has overperformed other stocks in the Biotechnology industry by 4.41 percentage points. Marker Therapeutics stock is currently +546.05% from its 52-week low of $0.67, and -55.22% from its 52-week high of $9.68.
At the moment, there are 8.9M MRKR shares outstanding. The market capitalization of MRKR is $38.59M. In the past 24 hours, 16,017 MRKR shares were traded.
You need an online brokerage account to access the NASDAQ market and buy MRKR stock.
Based on our research, eToro is the best place to buy stocks. Here's why:
Get $10 towards your stock purchase by signing up for an account with eToro today.
Open eToro AccountNow that you've chosen the right brokerage, you'll need to fill out some personal information so you can buy MRKR today.
Now that you've finished signing up on the best stock investing app, your next step is to transfer the money for your investment:
Watch the tutorial below if you need help transferring funds into your brokerage account.
Once you have selected the best place to buy Marker Therapeutics stock, it's absolutely critical to research their stock before you invest, so you actually wrap your head around the risk as well as the opportunity.
WallStreetZen was built to help part-time investors do better fundamental analysis.
You can see all of the due diligence checks on MRKR's stock page.
You can use many financial metrics, analyses, models, and charts to gauge MRKR's true value.
Using relative valuations measures:
You can do additional valuation research on MRKR's stock here.
You can dig deeper into what analysts are forecasting on the Marker Therapeutics stock forecast page.
Last year, MRKR revenue was $3.31M. Over the past five year, MRKR's revenue has increased by 74.27% per year. This was faster than the Biotechnology industry average of 29.77%.
Dig into MRKR's earnings and revenue performance here.
In the past year, insiders at MRKR have not bought or sold any shares.
Dig into more about who owns MRKR stock here.
No, Marker Therapeutics doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two primary order types:
Click the Open button and your broker will execute your order.
If you want more info about investing in stocks on eToro, watch the helpful video below:
Now that you own some MRKR shares, you'll want to keep up with your new stock purchase.
Put MRKR on a watchlist to see the latest developments about your MRKR stock.
To reiterate, here are the 6 steps to buy Marker Therapeutics stock:
If you need a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep track of your investment in Marker Therapeutics, click below.